- Home
- AVIR vs ERC Comparison
AVIR vs ERC Comparison
Compare AVIR & ERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- ERC
- Stock Information
- Founded
- AVIR 2012
- ERC 2003
- Country
- AVIR United States
- ERC United States
- Employees
- AVIR N/A
- ERC N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- ERC Finance/Investors Services
- Sector
- AVIR Health Care
- ERC Finance
- Exchange
- AVIR Nasdaq
- ERC Nasdaq
- Market Cap
- AVIR 290.4M
- ERC 262.9M
- IPO Year
- AVIR 2020
- ERC N/A
- Fundamental
- Price
- AVIR $2.97
- ERC $9.63
- Analyst Decision
- AVIR Hold
- ERC
- Analyst Count
- AVIR 1
- ERC 0
- Target Price
- AVIR $6.00
- ERC N/A
- AVG Volume (30 Days)
- AVIR 223.7K
- ERC 64.4K
- Earning Date
- AVIR 11-06-2025
- ERC 01-01-0001
- Dividend Yield
- AVIR N/A
- ERC 8.37%
- EPS Growth
- AVIR N/A
- ERC N/A
- EPS
- AVIR N/A
- ERC 0.72
- Revenue
- AVIR N/A
- ERC N/A
- Revenue This Year
- AVIR N/A
- ERC N/A
- Revenue Next Year
- AVIR N/A
- ERC N/A
- P/E Ratio
- AVIR N/A
- ERC $12.92
- Revenue Growth
- AVIR N/A
- ERC N/A
- 52 Week Low
- AVIR $2.46
- ERC $8.51
- 52 Week High
- AVIR $4.10
- ERC $9.74
- Technical
- Relative Strength Index (RSI)
- AVIR 33.48
- ERC 59.21
- Support Level
- AVIR $2.84
- ERC $9.59
- Resistance Level
- AVIR $3.33
- ERC $9.72
- Average True Range (ATR)
- AVIR 0.14
- ERC 0.06
- MACD
- AVIR -0.04
- ERC 0.00
- Stochastic Oscillator
- AVIR 18.98
- ERC 61.54
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About ERC Allspring Multi-Sector Income Fund
Allspring Multi-Sector Income Fund is a closed-end investment management company. The company's core business is to secure a high level of income for its investors consistent with limiting its overall exposure to domestic interest rate risk. It invests in U.S. dollar-denominated below investment-grade bonds, debentures, and other income obligations, including loans and preferred stocks, developed and emerging market debt securities, including obligations of foreign governments or governmental entities, foreign corporations, or supranational agencies denominated in various currencies, asset backed securities and investment grade corporate bonds.